1982
DOI: 10.1038/296352a0
|View full text |Cite
|
Sign up to set email alerts
|

Adhesion-dependent heparin production by platelets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

1983
1983
2004
2004

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 7 publications
1
6
0
Order By: Relevance
“…Among plasmatic GAGs, heparin is the most interesting one for its anticoagulant/antithrombotic properties, but it is also the most elusive one. Plasmatic heparin, together with heparin and heparan sulfate bound to endothelial cells, might play a physiological role in the maintenance of the hemostatic balance and might be involved in thrombotic/hemorrhagic pathologies [4][5][6][7][8]. The presence of heparin in human plasma was previously suggested, and all studies agree that heparin is associated with proteins or peptides [1,[9][10][11].…”
Section: Introductionsupporting
confidence: 57%
“…Among plasmatic GAGs, heparin is the most interesting one for its anticoagulant/antithrombotic properties, but it is also the most elusive one. Plasmatic heparin, together with heparin and heparan sulfate bound to endothelial cells, might play a physiological role in the maintenance of the hemostatic balance and might be involved in thrombotic/hemorrhagic pathologies [4][5][6][7][8]. The presence of heparin in human plasma was previously suggested, and all studies agree that heparin is associated with proteins or peptides [1,[9][10][11].…”
Section: Introductionsupporting
confidence: 57%
“…We hypothesize that they are part of native supramolecular structure(s) in which GAGs, including heparin, are vehicled in human plasma; alternatively, they could be generated by proteolysis of plasma proteins. Dilution of these peptides with loss of aggregation might play a role in the interaction between GAGs and endothelial cells [16] or platelets where dilution causes the release of heparin [19].…”
Section: Resultsmentioning
confidence: 99%
“…An endoglycosidase, present within platelet lysosomes (2,9,23), has been noted to both liberate and degrade heparan sulfate, a proteoglycan possessing heparin-like anticoagulant properties present on the surface of endothelial cells (2). Platelets themselves have been reported to release heparin after in vitro adhesion has been induced (32).…”
Section: Discussionmentioning
confidence: 99%